Publicaciones en las que colabora con ELIECER COTO GARCIA (24)

2021

  1. Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients

    Frontiers in Immunology, Vol. 12

  2. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2020

  1. IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association

    Cytokine, Vol. 136

2019

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

    Immunology Letters, Vol. 208, pp. 39-43

2018

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function

    Human Immunology, Vol. 79, Núm. 6, pp. 494-498

  2. Genetic Variation in the H19-IGF2 Cluster Might Confer Risk of Developing Impaired Renal Function

    DNA and Cell Biology, Vol. 37, Núm. 7, pp. 617-625

2017

  1. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT

    Epigenomics, Vol. 9, Núm. 8, pp. 1049-1057

2015

  1. A 3′-UTR polymorphism in soluble epoxide hydrolase gene is associated with acute rejection in renal transplant recipients

    PLoS ONE, Vol. 10, Núm. 7

  2. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: A Next Generation Sequencing approach

    Clinical Chemistry and Laboratory Medicine, Vol. 53, Núm. 10, pp. 1515-1519

  3. Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

    Human Immunology, Vol. 76, Núm. 2-3, pp. 75-78

  4. Next generation sequencing search for uromodulin gene variants related with impaired renal function

    Molecular Biology Reports, Vol. 42, Núm. 9, pp. 1353-1358

  5. The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients

    Journal of Human Genetics, Vol. 60, Núm. 5, pp. 273-276

2014

  1. Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort

    CardioRenal Medicine, Vol. 4, Núm. 2, pp. 82-87

  2. Farmacogenética del tacrolimus: ¿del laboratorio al paciente?

    Nefrologia, Vol. 34, Núm. 1, pp. 11-17

  3. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients

    Gene, Vol. 538, Núm. 1, pp. 195-198

  4. Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. A CLCNKA polymorphism (rs10927887; p.Arg83Gly) previously linked to heart failure is associated with the estimated glomerular filtration rate in the RENASTUR cohort

    Gene, Vol. 527, Núm. 2, pp. 670-672

  2. A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients

    Pharmacogenetics and Genomics, Vol. 23, Núm. 8, pp. 445-448

2012

  1. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus

    Molecular Genetics and Metabolism, Vol. 105, Núm. 3, pp. 525-527

2011

  1. Erratum: Pharmacogenetics of tacrolimus after renal transplantation: Analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes (Clinical Chemistry and Laboratory Medicine (2011) 49:5 (825-833))

    Clinical Chemistry and Laboratory Medicine